Ethyl (2E)-3-(pyridin-2-yl)acrylate - Names and Identifiers
Ethyl (2E)-3-(pyridin-2-yl)acrylate - Physico-chemical Properties
Molecular Formula | C10H11NO2
|
Molar Mass | 177.2 |
Density | 1.106g/cm3 |
Boling Point | 90-92°C/1 mm |
Flash Point | 125°C |
Solubility | Dichloromethane, Ethyl Acetate |
Vapor Presure | 0.00322mmHg at 25°C |
Appearance | Oil |
Color | Colourless |
Storage Condition | 2-8°C |
Refractive Index | 1.553 |
Ethyl (2E)-3-(pyridin-2-yl)acrylate - Introduction
ethyl (2E)-3-pyridin-2-ylprop-2-enoate is an organic compound with the chemical formula C11H11NO2. The following is an introduction to its nature, use, formulation and safety information:
Nature:
-Appearance: colorless liquid
-Melting Point: Uncertain
-Boiling point: About 300 ℃
-The calculated molecular weight is about 193.21g/mol
-Soluble in organic solvents such as ethers and alcohols
Use:
- ethyl (2E)-3-pyridin-2-ylprop-2-enoate has a wide range of applications in the fields of medicinal chemistry and materials science.
-It can be used as an intermediate for the synthesis of antibiotics, anti-cancer drugs and other biologically active molecules.
-In materials science, it can be used as a monomer or ligand of polymers to participate in various synthetic reactions.
Method:
- ethyl (2E)-3-pyridin-2-ylprop-2-enoate can be obtained by reacting pyridine and ethyl acrylate under appropriate conditions.
-A possible synthesis method is to react pyridine with ethyl acrylate in a solvent under an inert atmosphere, and add a catalyst to promote the reaction.
Safety Information:
- ethyl (2E)-3-pyridin-2-ylprop-2-enoate is irritating to the skin, eyes and respiratory tract and should be avoided.
-Appropriate protective measures must be taken during use or operation, such as wearing protective gloves, goggles and respiratory protective equipment.
-Avoid inhaling its vapors and maintain a well-ventilated working environment.
-If ingested by mistake or in contact with skin, seek medical attention immediately and bring the compound's safety data sheet with you.
Last Update:2024-04-09 02:00:44